Activation syndrome caused by paroxetine in a cancer patient

Palliative and Supportive Care

Volumn 6, Issue 2, 2008, Pages 183-185

  Nishida, Tomomi ^a   Wada, Makoto ^a   Wada, Mei ^a   Ito, Hiroshi ^a   Narabayashi, Masaru ^a   Onishi, Hideki ^a  

^a SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

Author keywords

Activation syndrome; Akathisia; Cancer; Paroxetine; Selective serotonin reuptake inhibitors (SSRIs)

Indexed keywords

PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

AKATHISIA; ARTICLE; AUTOMUTILATION; CASE REPORT; CHEMICALLY INDUCED DISORDER; HUMAN; MAJOR DEPRESSION; MALE; MIDDLE AGED; PANCREAS TUMOR; PSYCHOLOGICAL ASPECT; SYNDROME;

AKATHISIA, DRUG-INDUCED; DEPRESSIVE DISORDER, MAJOR; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PAROXETINE; SELF-INJURIOUS BEHAVIOR; SEROTONIN UPTAKE INHIBITORS; SYNDROME;

EID: 44449139547     PISSN: 14789515     EISSN: 14789523     Source Type: Journal    
DOI: 10.1017/S1478951508000278     Document Type: Article

References (8)

1. Breggin, P.R. (2003/2004). Suicidality, violence and mania caused by selective serotonin reuptake inhibitors (SSRIs): A review and analysis. International Journal of Risk & Safety in Medicine, 16, 31-49.
2. Culpepper, L., Davidson, J.R.T., Dietrich, A.J., et al. (2004). Suicidality as a possible side effect of antidepressant treatment. Primary Care Companion Journal of Clinical Psychiatry, 6, 79-86.
3. Leo, R.J. (1996). Movement disorders associated with the serotonin selective reuptake inhibitors. Journal of Clinical Psychiatry, 57, 449-454.
4. Lipinski, J.F., Jr., Mallya, G., Zimmerman, P., et al. (1989). Fluoxetine-induced akathisia: Clinical and theoretical implications. Journal of Clinical Psychiatry, 50, 339-342.
5. MacGillivray, S., Arroll, B., Hatcher, S., et al. (2003). Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: Systematic review and meta-analysis. British Medical Journal, 326, 1014-1017.
6. Rodin, G., Lloyd, N., Katz, M., et al. (2007). The treatment of depression in cancer patients: A systematic review. Supportive Care in Cancer, 15, 123-136.
7. Teicher, M.H., Glod, C., & Cole, J.O. (1990). Emergence of intense suicidal preoccupation during fluoxetine treatment. American Journal of Psychiatry, 147, 207-210.
8. Wagstaff, A.J., Cheer, S.M., Matheson, A.J., et al. (2002). Spotlight on paroxetine in psychiatric disorders in adults. CNS Drugs, 16, 425-434.